South Korea's production of medical equipment and related materials went up to 7.3 trillion won in 2019, 11.8 percent higher than the previous year.
Dental implants, the top product for the third straight year, accounted for 1.4 trillion won.
Ultrasound diagnostic machines were second and dermal fillers came it at third.
There is a high demand for dental care products due to aging with people 65 years or older, accounting for 14.2 percent of South Korea's population in 2018.
The inclusion of dental treatment under public health insurance made it less expensive, contributing to the increased demand.
Exportation of medical equipment and materials surged 8.9 percent on-year to 4.3 trillion won, with ultrasound machines the top item.
China was the top export destination with 715 billion won, the United States came in second with 676 billion won, and followed by Germany with 276 billion won.
Meanwhile, importations went up 13.3 percent to 4.8 trillion won, with soft contact lens being the No. 1 import product.


Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



